ROLE OF SERUM CARDIAC MARKERS IN DIAGNOSIS OF ACUTE CHEST PAIN

Abstract

Acute myocardial infarction (AMI) continues to be a major health problem in industrialized and developing countries like India despite progressive research in diagnostic and management over last three decades.AMI has typically been diagnosed on the basis of triad of clinical syndromes of chest pain, electrocardiogram (ECG) changes and elevated serum enzyme activity.Due to high cardiac specificity of ckmb,cTnI, these biomarkers have become the recommended biomarkers for the diagnosis of myocardial injury